BG
CGEM icon

Baupost Group’s Cullinan Oncology CGEM Stock Holding History

Baupost Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-429,646
Closed -$5.51M – 35
2022
Q3 		$5.51M Sell
429,646
-1,105,914
-72% -$14.9M 0.1% 33
2022
Q2 		$19.7M Hold
1,535,560
– – 0.29% 32
2022
Q1 		$16.1M Hold
1,535,560
– – 0.17% 36
2021
Q4 		$22.5M Sell
1,535,560
-300,000
-16% -$5.98M 0.22% 36
2021
Q3 		$40.2M Hold
1,835,560
– – 0.37% 30
2021
Q2 		$46.3M Hold
1,835,560
– – 0.38% 29
2021
Q1 		$71.7M Buy
+1,835,560
New +$74.5M 0.57% 30

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Baupost Group's CGEM Position: Q4 2022 in Review

Baupost Group sold out of Cullinan Oncology (CGEM) in Q4 2022, closing a stake of 429,646 shares — an estimated $5.51M sold.

Baupost Group first reported a position in CGEM in Q1 2021 and held it in 7 quarters. The position peaked at $71.7M in Q1 2021. 97 funds tracked by Wall St. Rank hold CGEM as of Q4 2022.

  • Baupost Group reported no remaining Cullinan Oncology position as of Q4 2022 after selling out during the quarter.
  • Baupost Group sold 429,646 Cullinan Oncology shares in Q4 2022, an estimated $5.51M.
  • Baupost Group first reported a position in Cullinan Oncology in Q1 2021 and held it in 7 quarters.
  • Baupost Group's Cullinan Oncology position peaked at $71.7M in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2022.

Based on Baupost Group's 13F filing for Q4 2022, filed 13 Feb 2023.